Inhibitory activities of epidermal growth factor receptor tyrosine kinase-targeted dihydroxyisoflavone and trihydroxydeoxybenzoin derivatives on Sarcocystis neurona, Neospora caninum, and Cryptospondium parvum development

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 11, 2005, Pages 4628-4634

  Gargala, G ^a   Baishanbo, A ^a   Favennec, L ^a   Francois A ^a   Ballet, J J ^b,d   Rossignol, J F ^c  

^a HÔPITAL CHARLES NICOLLE   (France)

^b CHU Clemenceau   (France)

^c Romark Laboratories   (United States)

^d CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,4,6 TRIHYDROXYDEOXYBENZOIN; 5,7 DIHYDROXYISOFLAVONE; COCCIDIOSTATIC AGENT; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; ISOFLAVONE DERIVATIVE; NITAZOXANIDE; PAROMOMYCIN; RM 6427; RM 6428; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYPTOSPORIDIUM PARVUM; CULTURE MEDIUM; DISEASE MODEL; DRUG CYTOTOXICITY; DRUG STRUCTURE; FECES ANALYSIS; FEMALE; FLOW CYTOMETRY; GERBIL; HEPATOBILIARY SYSTEM; HOST PARASITE INTERACTION; ILEUM; IMMUNE DEFICIENCY; MALE; NEOSPORA CANINUM; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; OOCYST; PRIORITY JOURNAL; PROTOZOAL INFECTION; SARCOCYSTIS NEURONA;

ANIMALS; CATTLE; CELL LINE; COCCIDIOSTATS; CRYPTOSPORIDIUM PARVUM; FEMALE; ISOFLAVONES; NEOSPORA; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SARCOCYSTIS;

EID: 27644480273     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.11.4628-4634.2005     Document Type: Article

References (41)

1. Akiyama, T., and H. Ogawara. 1991. Use specificity of genistein as inhibitor of protein tyrosine kinase. Methods Enzymol. 201:362-370.
2. Akiyama, T., J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, and Y. Fukami. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:5592-5595.
3. Baishanbo, A., G. Gargala, A. Delaunay, A. François, J.-J. Ballet, and L. Favennec. 2005. Infectivity of Cryptosporidium hominis and Cryptosporidium parvum genotype 2 isolates in immunosuppressed Mongolian gerbils. Infect. Immun. 73:5252-5255.
4. Barnes, D. A., A. Bonnin, J. X. Huang, L. Gousset, J. Wu, J. Gut, P. Doyle, J. F. Dubremetz, H. Ward, and C. Petersen. 1998. A novel multi-domain mucin-like glycoprotein of Cryptosporidium parvum mediates invasion. Mol. Biochem. Parasitol. 96:93-110.
5. Broekhuysen, J., A. Stockis, R. L. Lins, J. De Graeve, and J. F. Rossignol. 2000. Nitazoxanide: pharmacokinetics and metabolism in man. Int. J. Clin. Pharmacol. Ther. 38:387-394.
6. Buret, A., D. G. Gall, M. E. Olson, and J. A. Hardin. 1999. The role of the epidermal growth factor receptor in microbial infections of the gastrointestinal tract. Microbes Infect. 1:1139-1144.
7. Buret, A. G., A. C. Chin, and K. G. Scott. 2003. Infection of human and bovine epithelial cells with Cryptosporidium andersoni induces apoptosis and disrupts tight junctional ZO-1: effects of epidermal growth factor. Int. J. Parasitol. 33:1363-1371.
8. Campbell, I. D., and P. Bork. 1993. Epidermal growth factor-like modules. Curr. Opin. Struct. Biol. 3:385-392.
9. Carpenter, G., L. King, Jr., and S. Cohen. 1979. Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor. J. Biol. Chem. 254:4884-4891.
10. Carruthers, V. B., O. K. Giddings, and L. D. Sibley. 1999. Secretion of micronemal proteins is associated with Toxoplasma invasion of host cells. Cell. Microbiol. 1:225-235.
11. Dillingham, R. A., A. A. Lima, and R. L. Guerrant. 2002. Cryptosporidiosis: epidemiology and impact. Microbes Infect. 4:1059-1066.
12. Doerig, C., L. Meijer, and J. C. Mottram. 2002. Protein kinases as drug targets in parasitic protozoa. Trends Parasitol. 18:366-371.
13. Dubey, J. P. 1999. Neosporosis-the first decade of research. Int. J. Parasitol. 29:1485-1488.
14. Dubey, J. P., D. S. Lindsay, W. J. Saville, S. M. Reed, D. E. Granstrom, and C. A. Speer. 2001. A review of Sarcocystis neurona and equine protozoal myeloencephalitis (EPM). Vet. Parasitol. 95:89-131.
15. Dubey, J. P., A. L. Hattel, D. S. Lindsay, and M. J. Topper. 1988. Neonatal Neospora caninum infection in dogs: isolation of the causative agent and experimental transmission. J. Am. Vet. Med. Assoc. 193:1259-1263.
16. Ellison, S. P., E. Greiner, and J. B. Dame. 2001. In vitro culture and synchronous release of Sarcocystis neurona merozoites from host cells. Vet. Parasitol. 95:251-261.
17. Ferreira, S., T. M. De Carvalho, and W. J. De Souza. 2003. Protein phosphorylatton during the process of interaction of Toxoplasma gondii with host cells. J. Submicrosc. Cytol. Pathol. 35:245-252.
18. Forney, J. R., D. B. DeWald, S. Yang, C. A. Speer, and M. C. Healey. 1999. A role for host phosphoinositide 3-kinase and cytoskeletal remodeling during Cryptosporidium parvum infection. Infect. Immun. 67:844-852.
19. Garcia-Reguet, N., M. Lebrun, M. N. Fourmaux, O. Mercereau-Puijalon, T. Mann, C. J. Beckers, B. Samyn, J. Van Beeumen, D. Bout, and J. F. Dubremetz. 2000. The microneme protein MIC3 of Toxoplasma gondii is a secretory adhesin that binds to both the surface of the host cells and the surface of the parasite. Cell. Microbiol. 2:353-364.
20. Gargala, G., A. Delaunay, X. Li, P. Brasseur, L. Favennec, and J. J. Ballet. 2000. Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells. J. Antimicrob. Chemother. 46:57-60.
21. Hackel, P. O., E. Zwick, N. Prenzel, and A. Ullrich. 1999. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr. Opin. Cell Biol. 11:184-189.
22. Hide, G. 1998. Mammalian epidermal growth factor stimulates G-protein activity in Trypanosoma brucei. Parasitol. Res. 84:143-146.
23. Hide, G., A. Gray, C. M. Harrison, and A. Tait. 1989. Identification of an epidermal growth factor receptor homologue in trypanosomes. Mol. Biochem. Parasitol. 36:51-59.
24. Hubbard, S. R., and J. H. Till. 2000. Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 69:373-398.
25. Knockaert, M., P. Greengard, and L. Meijer. 2002. Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol. Sci. 23:417-425.
26. Lindsay, D. S., and J. P. Dubey. 1989. In vitro development of Neospora caninum (Protozoa; Apicomplexa) from dogs. J. Parasitol. 75:163-165.
27. Lindsay, D. S., N. J. Thomas, and J. P. Dubey. 2000. Biological characterisation of Sarcocystis neurona isolated from a Southern sea otter (Enhydra lutris nereis). Int. J. Parasitol. 30:617-624.
28. Maillot, C., G. Gargala, A. Delaunay, P. Ducrotte, P. Brasseur, J. J. Ballet, and L. Favennec. 2000. Cryptosporidium parvum infection stimulates the secretion of TGF-beta, IL-8 and RANTES by Caco-2 cell line. Parasitol. Res. 86:947-949.
29. Meissner, M., M. Reiss, N. Viebig, V. B. Carruthers, C. Toursel, S. Tomavo, J. W. Ajioka, and D. Soldati. 2002. A family of transmembrane microneme proteins of Toxoplasma gondii contain EGF-like domains and function as escorters. J. Cell Sci. 115:563-574.
30. Moghal, N., and P. W. Sternberg. 1999. Multiple positive and negative regulators of signaling by the EGF-receptor. Curr. Opin. Cell Biol. 11:190-196.
31. Morisaki, J. H., J. E. Heuser, and L. D. Sibley. 1995. Invasion of Toxoplasma gondii occurs by active penetration of the host cell. J. Cell Sci. 108:2457-2464.
32. 3 mediates adhesion of Neospora caninum tachyzoites to host cells unlike that in Toxoplasma gondii. Int. J. Parasitol. 32:695-704.
33. Naguleswaran, A., A. Cannas, N. Keller, N. Vonlaufen, G. Schares, F. J. Conraths, C. Björkman, and A. Hemphill. 2001. Neospora caninum microneme protein NcMIC3: secretion, subcellular localization, and functional involvement in host cell interaction. Infect. Immun. 69:6483-6494.
34. Shaw, M. K. 1996. Theileria parva sporozoite entry into bovine lymphocytes involves both parasite and host cell signal transduction processes. Exp. Parasitol. 84:344-354.
35. Stockis, A., X. Deroubaix, R. Lins, B. Jeanbaptiste, P. Calderon, and J. F. Rossignol. 1996. Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers. Int. J. Clin. Pharmacol. Ther. 34:349-351.
36. Tomley, F. M., K. J. Billington, J. M. Bumstead, J. D. Clark, and P. Monaghan. 2001. EtMIC4: a microneme protein from Eimeria tenella that contains tandem arrays of epidermal growth factor-like repeats and thrombospondin type-1 repeats. Int. J. Parasitol. 31:1303-1310.
37. Traxler, P., J. Green, H. Mett, U. Sequin, and P. Furet. 1999. Use of a pharmacophore model for the design of EGFR tyrosine kinase inhibitors: isoflavones and 3-phenyl-4(1H)-quinolones. J. Med. Chem. 42:1018-1026.
38. Valdez, L. M., H. Dang, P. C. Okhuysen, and C. L. Chappell. 1997. Flow cytometric detection of Cryptosporidium oocysts in human stool samples. J. Clin. Microbiol. 35:2013-2017.
39. Van der Geer, P., T. Hunter, and R. A. Lindberg. 1994. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10:251-337.
40. Vieira, M. C., T. U. de Carvalho, and W. de Souza. 1994. Effect of protein kinase inhibitors on the invasion process of macrophages by Trypanosoma cruzi. Biochem. Biophys. Res. Commun. 203:967-971.
41. Ward, G. E., H. Fujioka, M. Aikawa, and L. H. Miller. 1994. Staurosporine inhibits invasion of erythrocytes by malarial merozoites. Exp. Parasitol. 79:480-487.